Autolus Therapeutics Stock Price History
| AUTL Stock | USD 2.41 0.01 0.41% |
Below is the normalized historical share price chart for Autolus Therapeutics extending back to June 22, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Autolus Therapeutics stands at 2.41, as last reported on the 20th of July, with the highest price reaching 2.49 and the lowest price hitting 2.39 during the day.
If you're considering investing in Autolus Stock, it is important to understand the factors that can impact its price. Autolus Therapeutics appears to be unstable, given 3 months investment horizon. Autolus Therapeutics secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2 % return per unit of risk over the last 3 months. By analyzing Autolus Therapeutics' technical indicators, you can evaluate if the expected return of 0.93% is justified by implied risk. Please makes use of Autolus Therapeutics' Risk Adjusted Performance of 0.2051, mean deviation of 3.78, and Downside Deviation of 4.32 to double-check if our risk estimates are consistent with your expectations. At this time, Autolus Therapeutics' Common Stock Shares Outstanding is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 821.9 M this year, although the value of Preferred Stock Total Equity will most likely fall to 1,092. . Price Earnings To Growth Ratio is expected to rise to 0.14 this year, although the value of Price To Sales Ratio will most likely fall to 56.29. Autolus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of June 2018 | 200 Day MA 2.3788 | 50 Day MA 1.9968 | Beta 1.739 |
Sharpe Ratio = 0.1951
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AUTL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.78 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.93 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Autolus Therapeutics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Autolus Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.7283 | Enterprise Value Ebitda 0.0326 | Price Sales 71.1789 | Shares Float 119.1 M | Wall Street Target Price 9.8556 |
Autolus Therapeutics Stock Price History Chart
There are several ways to analyze Autolus Stock price data. The simplest method is using a basic Autolus candlestick price chart, which shows Autolus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 14, 2025 | 2.65 |
| Lowest Price | May 6, 2025 | 1.18 |
Autolus Therapeutics July 20, 2025 Stock Price Synopsis
Various analyses of Autolus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Autolus Stock. It can be used to describe the percentage change in the price of Autolus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Autolus Stock.| Autolus Therapeutics Price Action Indicator | (0.03) | |
| Autolus Therapeutics Price Rate Of Daily Change | 1.00 | |
| Autolus Therapeutics Price Daily Balance Of Power | (0.10) |
Autolus Therapeutics July 20, 2025 Stock Price Analysis
Autolus Stock Price History Data
The price series of Autolus Therapeutics for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 1.47 with a coefficient of variation of 24.91. The prices are distributed with arithmetic mean of 1.85. The median price for the last 90 days is 1.91.| Open | High | Low | Close | Volume | ||
07/20/2025 | 2.43 | 2.49 | 2.39 | 2.41 | ||
07/18/2025 | 2.43 | 2.49 | 2.39 | 2.41 | 1,498,418 | |
07/17/2025 | 2.46 | 2.47 | 2.40 | 2.42 | 784,905 | |
07/16/2025 | 2.51 | 2.56 | 2.39 | 2.44 | 952,633 | |
| 07/15/2025 | 2.69 | 2.69 | 2.47 | 2.49 | 1,679,748 | |
07/14/2025 | 2.50 | 2.67 | 2.46 | 2.65 | 1,874,469 | |
07/11/2025 | 2.45 | 2.52 | 2.40 | 2.47 | 1,132,599 | |
07/10/2025 | 2.47 | 2.50 | 2.41 | 2.48 | 917,657 | |
07/09/2025 | 2.38 | 2.53 | 2.37 | 2.47 | 1,454,595 | |
07/08/2025 | 2.27 | 2.38 | 2.24 | 2.36 | 1,346,493 | |
07/07/2025 | 2.37 | 2.38 | 2.24 | 2.26 | 2,688,589 | |
07/03/2025 | 2.35 | 2.38 | 2.32 | 2.37 | 451,120 | |
07/02/2025 | 2.28 | 2.44 | 2.25 | 2.35 | 1,571,012 | |
07/01/2025 | 2.28 | 2.34 | 2.19 | 2.29 | 1,606,458 | |
| 06/30/2025 | 2.31 | 2.35 | 2.24 | 2.28 | 2,317,332 | |
06/27/2025 | 2.29 | 2.34 | 2.24 | 2.31 | 2,091,972 | |
06/26/2025 | 2.30 | 2.34 | 2.26 | 2.31 | 1,331,632 | |
06/25/2025 | 2.27 | 2.32 | 2.19 | 2.32 | 1,713,166 | |
| 06/24/2025 | 2.24 | 2.28 | 2.17 | 2.27 | 1,510,366 | |
06/23/2025 | 2.05 | 2.21 | 2.01 | 2.21 | 2,232,882 | |
06/20/2025 | 2.06 | 2.09 | 2.00 | 2.05 | 1,781,282 | |
06/18/2025 | 2.02 | 2.10 | 1.98 | 2.06 | 1,527,964 | |
06/17/2025 | 2.03 | 2.07 | 2.00 | 2.03 | 2,695,424 | |
06/16/2025 | 2.14 | 2.15 | 2.00 | 2.05 | 2,753,601 | |
| 06/13/2025 | 2.05 | 2.18 | 2.05 | 2.12 | 1,894,892 | |
| 06/12/2025 | 2.24 | 2.26 | 2.12 | 2.15 | 2,812,382 | |
06/11/2025 | 2.37 | 2.37 | 2.21 | 2.24 | 2,724,618 | |
06/10/2025 | 2.37 | 2.42 | 2.26 | 2.33 | 2,326,769 | |
06/09/2025 | 2.39 | 2.39 | 2.26 | 2.35 | 2,731,481 | |
| 06/06/2025 | 2.28 | 2.43 | 2.28 | 2.34 | 2,654,849 | |
06/05/2025 | 2.10 | 2.27 | 2.04 | 2.26 | 3,130,301 | |
06/04/2025 | 2.17 | 2.21 | 2.07 | 2.09 | 3,616,338 | |
06/03/2025 | 1.98 | 2.17 | 1.94 | 2.07 | 5,901,011 | |
06/02/2025 | 1.78 | 1.95 | 1.75 | 1.91 | 2,006,131 | |
05/30/2025 | 1.75 | 1.78 | 1.69 | 1.75 | 1,685,156 | |
| 05/29/2025 | 1.69 | 1.79 | 1.68 | 1.75 | 2,296,914 | |
05/28/2025 | 1.57 | 1.67 | 1.54 | 1.65 | 1,448,466 | |
05/27/2025 | 1.57 | 1.59 | 1.52 | 1.57 | 1,992,280 | |
05/23/2025 | 1.53 | 1.54 | 1.49 | 1.54 | 1,153,889 | |
05/22/2025 | 1.48 | 1.54 | 1.48 | 1.53 | 970,292 | |
05/21/2025 | 1.51 | 1.59 | 1.46 | 1.47 | 1,994,516 | |
05/20/2025 | 1.47 | 1.56 | 1.45 | 1.53 | 2,434,683 | |
05/19/2025 | 1.34 | 1.49 | 1.34 | 1.48 | 3,088,087 | |
05/16/2025 | 1.29 | 1.36 | 1.29 | 1.33 | 2,827,416 | |
05/15/2025 | 1.21 | 1.30 | 1.19 | 1.29 | 1,590,116 | |
| 05/14/2025 | 1.28 | 1.30 | 1.19 | 1.22 | 1,980,810 | |
05/13/2025 | 1.37 | 1.38 | 1.22 | 1.27 | 3,053,429 | |
05/12/2025 | 1.35 | 1.47 | 1.34 | 1.35 | 3,216,776 | |
05/09/2025 | 1.36 | 1.48 | 1.32 | 1.32 | 2,763,828 | |
05/08/2025 | 1.46 | 1.48 | 1.30 | 1.35 | 5,462,688 | |
05/07/2025 | 1.18 | 1.25 | 1.15 | 1.23 | 2,990,283 | |
05/06/2025 | 1.33 | 1.33 | 1.18 | 1.18 | 1,935,258 | |
05/05/2025 | 1.36 | 1.37 | 1.30 | 1.33 | 1,339,762 | |
05/02/2025 | 1.36 | 1.44 | 1.35 | 1.35 | 3,020,504 | |
05/01/2025 | 1.42 | 1.43 | 1.33 | 1.35 | 1,355,422 | |
04/30/2025 | 1.28 | 1.41 | 1.27 | 1.41 | 1,733,416 | |
04/29/2025 | 1.39 | 1.39 | 1.29 | 1.31 | 2,156,427 | |
04/28/2025 | 1.35 | 1.41 | 1.29 | 1.39 | 2,288,930 | |
04/25/2025 | 1.41 | 1.41 | 1.30 | 1.33 | 2,740,914 | |
04/24/2025 | 1.56 | 1.56 | 1.34 | 1.40 | 3,275,165 | |
04/23/2025 | 1.65 | 1.72 | 1.42 | 1.51 | 2,583,094 |
About Autolus Therapeutics Stock history
Autolus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Autolus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Autolus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Autolus Therapeutics stock prices may prove useful in developing a viable investing in Autolus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 255.2 M | 267.9 M | |
| Net Loss | -134 M | -127.3 M |
Autolus Therapeutics Quarterly Net Working Capital |
|
Autolus Therapeutics Stock Technical Analysis
Autolus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Autolus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Autolus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Autolus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Autolus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2051 | |||
| Jensen Alpha | 0.8202 | |||
| Total Risk Alpha | 0.3276 | |||
| Sortino Ratio | 0.1998 | |||
| Treynor Ratio | 0.7497 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Autolus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autolus Therapeutics. If investors know Autolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Autolus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.88) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Autolus Therapeutics is measured differently than its book value, which is the value of Autolus that is recorded on the company's balance sheet. Investors also form their own opinion of Autolus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Autolus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Autolus Therapeutics' market value can be influenced by many factors that don't directly affect Autolus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Autolus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Autolus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Autolus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.